Clinical study investigating the pharmacokinetics and bioavailability of oral hydroxyprogesterone [LPCN 1107] vs intramuscular hydroxyprogesterone in pregnant women
Phase of Trial: Phase I
Latest Information Update: 12 Jan 2015
Price : $35 *
At a glance
- Drugs Hydroxyprogesterone (Primary) ; Hydroxyprogesterone
- Indications Preterm labour
- Focus Adverse reactions; Pharmacokinetics
- 08 Sep 2014 Topline results expected in 2015, according to a Lipocine media release.
- 08 Sep 2014 First patient dosed, according to a Lipocine media release.
- 08 Sep 2014 Status changed from planning to recruiting, as reported in a Lipocine media release.